Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities.

Autor: El Safadi D; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Hitchins L; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Howard A; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Aley P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom., Bowman J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Bertran M; Immunisations and Vaccine Preventable Diseases, UK Health Security Agency (UKHSA), London, United Kingdom., Collins A; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Colin-Jones R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Elterish F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Fry NK; Immunisations and Vaccine Preventable Diseases, UK Health Security Agency (UKHSA), London, United Kingdom., Gordon SB; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Gould K; Institute for Infection and Immunity, St George's University, London, United Kingdom.; BUGS Bioscience, London Bioscience Innovation Centre, London, United Kingdom., Hinds J; Institute for Infection and Immunity, St George's University, London, United Kingdom.; BUGS Bioscience, London Bioscience Innovation Centre, London, United Kingdom., Horn E; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Hyder-Wright A; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Kandasamy R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Ladhani S; Immunisations and Vaccine Preventable Diseases, UK Health Security Agency (UKHSA), London, United Kingdom., Litt D; Immunisations and Vaccine Preventable Diseases, UK Health Security Agency (UKHSA), London, United Kingdom., Mitsi E; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Murphy A; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom.; National Institute for Health Research Clinical Research Network, Thames Valley and South Midlands, Oxford, United Kingdom., Pojar S; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Ratcliffe H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Robertson MC; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom.; National Institute for Health Research Clinical Research Network, Thames Valley and South Midlands, Oxford, United Kingdom., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research, Oxford Biomedical Research Centre, Oxford, United Kingdom., Solórzano C; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Begier E; Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA., Catusse J; Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA., Lahuerta M; Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA., Theilacker C; Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA., Gessner BD; Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA., Tiley KS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Ferreira DM; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Jul 16. Date of Electronic Publication: 2024 Jul 16.